AGAP3 and colorectal cancer: Studies using patient-derived colorectal cancer organoids to compare BRAF fusions with various fusion partners (TRIM24, AGAP3, and DLG1) have shown that the 5′ partner plays a role in signaling and localization that affects signaling pathways and gene expression [24].